 
|
|
LECTURES
& BREAKOUTS
Gastric Cancer State
of the Science Workshop
Tuesday, March 6, 2001 |
|
Time
|
Title |
Speaker |
|
|
|
|
8:00
|
Welcome
and Introduction |
John
S. Macdonald, M.D. |
|
|
|
|
8:15
|
Present
Status |
Pelayo
Correa, M.D.
|
|
| Steven
M. Powell, M.D. |
|
| Martin
S. Karpeh, M.D. |
|
| John
S. Macdonald, M.D. |
|
Question
& Answer
|
|
|
|
| 10:00
|
How
Do We Define Premalignant Lesions and What Is the Significance
of These Lesions? |
Steven
F. Moss, M.D. |
|
| Cecilia
Fenoglio-Preiser, M.D. |
|
| Stuart
Spechler, M.D. * |
|
| Question
& Answer |
|
|
|
| 1:00
|
Can
We Define the Best Molecular Pathways (Targets) for Future Investigations? |
James L. Abbruzzese,
M.D. *
|
|
| David
J. McConkey, Ph.D. |
|
| Lee
M. Ellis, M.D. * |
|
| Robert
Radinsky, Ph.D. * |
|
| Question
& Answer |
|
|
|
| 3:00
|
What
Clinical Trial Designs Will Facilitate Development of Target-Directed
Therapies? |
Richard
L. Schilsky, M.D.
|
|
| Emily
Bergsland, M.D. |
|
| Gary
L. Rosner, Sc.D. |
|
| Richard
L. Wahl, M.D. |
|
| Question
& Answer |
|
|
|
|
Wednesday,
March 7, 2001
|
|
Time
|
Title |
Speaker |
|
|
|
|
8:00
|
How
Do We Best Acheive Loco-Regional Control of Gastric Cancer?
|
Leonard
L. Gunderson, M.D. |
|
| Scott
A. Hundahl, M.D. F.A.C.S. |
|
| David
Kelsen, M.D. |
|
| Leonard
L. Gunderson, M.D. |
  |
|
Question &
Answer
|
|
|
|
|
8:15
|
Why
is Gastric Cancer Resistant to Therapy and Are There Ways to Overcome
Resistance? |
Branimir
I Sikic, M.D. |
|
| Gary
K Schwartz, M.D. |
|
| Heinz-Josef
Lenz, M.D. |
|
| James
M. Ford, M.D. |
|
|
|
| |
Conference
Summary |
Charles
Fuchs, M.D. |
|
*Presentations not available
online. |
